225 related articles for article (PubMed ID: 25708291)
1. Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone.
Seo NK; Koo HS; Haam JH; Kim HY; Kim MJ; Park KC; Park KS; Kim YS
J Gastroenterol Hepatol; 2015 Jul; 30(7):1211-6. PubMed ID: 25708291
[TBL] [Abstract][Full Text] [Related]
2. Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
Yim JY; Kim J; Kim D; Ahmed A
Liver Int; 2018 Nov; 38(11):2051-2059. PubMed ID: 29517842
[TBL] [Abstract][Full Text] [Related]
3. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
[TBL] [Abstract][Full Text] [Related]
5. Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.
Liu G; Zheng X; Guan L; Jiang Z; Lin H; Jiang Q; Zhang N; Zhang Y; Zhang X; Yu C; Guan Q
Endocr Res; 2015; 40(4):188-93. PubMed ID: 25531861
[TBL] [Abstract][Full Text] [Related]
6. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease.
Dai YN; Zhu JZ; Fang ZY; Zhao DJ; Wan XY; Zhu HT; Yu CH; Li YM
Metabolism; 2015 Dec; 64(12):1667-73. PubMed ID: 26476959
[TBL] [Abstract][Full Text] [Related]
7. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease.
Ryu S; Chang Y; Jung HS; Yun KE; Kwon MJ; Choi Y; Kim CW; Cho J; Suh BS; Cho YK; Chung EC; Shin H; Kim YS
J Hepatol; 2015 Nov; 63(5):1229-37. PubMed ID: 26385766
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease is not associated with a lower health perception.
Mlynarsky L; Schlesinger D; Lotan R; Webb M; Halpern Z; Santo E; Shibolet O; Zelber-Sagi S
World J Gastroenterol; 2016 May; 22(17):4362-72. PubMed ID: 27158205
[TBL] [Abstract][Full Text] [Related]
9. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
[TBL] [Abstract][Full Text] [Related]
11. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study.
Kim JY; Lee C; Oh M; Im JA; Lee JW; Chu SH; Lee H; Jeon JY
Clin Chim Acta; 2016 Jul; 458():12-7. PubMed ID: 27020118
[TBL] [Abstract][Full Text] [Related]
12. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension.
Sung KC; Wild SH; Byrne CD
J Hepatol; 2014 May; 60(5):1040-5. PubMed ID: 24445219
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
14. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
[TBL] [Abstract][Full Text] [Related]
15. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
[TBL] [Abstract][Full Text] [Related]
16. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
[TBL] [Abstract][Full Text] [Related]
17. Serum Testosterone Level Within Normal Range Is Positively Associated with Nonalcoholic Fatty Liver Disease in Premenopausal but Not Postmenopausal Women.
Park JM; Lee HS; Oh J; Lee YJ
J Womens Health (Larchmt); 2019 Aug; 28(8):1077-1082. PubMed ID: 30653387
[No Abstract] [Full Text] [Related]
18. Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study.
Wang J; Zhu W; Huang S; Xu L; Miao M; Wu C; Yu C; Li Y; Xu C
Liver Int; 2017 Aug; 37(8):1202-1208. PubMed ID: 28106941
[TBL] [Abstract][Full Text] [Related]
19. The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease.
Chung GE; Kim D; Kwak MS; Yang JI; Yim JY; Lim SH; Itani M
Clin Mol Hepatol; 2016 Mar; 22(1):146-51. PubMed ID: 27044765
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
Wang Z; Xu M; Hu Z; Shrestha UK
Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
